Dysregulation of Mesenchymal Stromal Cell Antioxidant Responses in Progressive Multiple Sclerosis

The potential of autologous cell‐based therapies including those using multipotent mesenchymal stromal cells (MSCs) is being investigated for multiple sclerosis (MS) and other neurological conditions. However, the phenotype of MSC in neurological diseases has not been fully characterized. We have pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Redondo, Juliana, Sarkar, Pamela, Kemp, Kevin, Heesom, Kate J, Wilkins, Alastair, Scolding, Neil J, Rice, Claire M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2018
Materias:
Translational Research Articles and Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186266/
https://www.ncbi.nlm.nih.gov/pubmed/30063300
http://dx.doi.org/10.1002/sctm.18-0045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186266/
https://www.ncbi.nlm.nih.gov/pubmed/30063300
http://dx.doi.org/10.1002/sctm.18-0045

Ejemplares similares